Provided by Tiger Trade Technology Pte. Ltd.

Fractyl Health

4.46
+0.23105.46%
Volume:75.98K
Turnover:326.94K
Market Cap:58.98M
PE:-0.33
High:4.49
Open:4.21
Low:4.20
Close:4.23
52wk High:29.34
52wk Low:4.14
Shares:13.22M
Float Shares:10.67M
Volume Ratio:0.92
T/O Rate:0.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.4316
EPS(LYR):-22.3200
ROE:-778.33%
ROA:-74.57%
PB:-35.42
PE(LYR):-0.20

Loading ...

Fractyl Health Inc - Plans Rjva-001 Study in Australia; Regulatory Feedback Expected Q3 2026

THOMSON REUTERS
·
May 11

Fractyl Health Authorized to Initiate First-in-Human Trial of Rjva-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes

THOMSON REUTERS
·
May 11

Fractyl Health Inc - First Patient Dosing and Preliminary Data for Rjva-001 Expected in H2 2026

THOMSON REUTERS
·
May 11

Fractyl Health Inc - Rejuva Clinical Development Funded Into Early 2027 With No Change to Capital Plans

THOMSON REUTERS
·
May 11

Fractyl Health Authorized to Initiate First-in-Human Trial of RJVA-001 in the Netherlands: First Gene Therapy Candidate to Enter Clinical Development for Type 2 Diabetes

GlobeNewswire
·
May 11

Fractyl Health Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
May 09

Fractyl Health updates financial calendar ahead of quarterly results webcast

Reuters
·
May 05

Fractyl Health to Report First Quarter 2026 Financial Results and Provide Business Updates on May 12, 2026, and Will Participate in an Upcoming Investor Conference

GlobeNewswire
·
May 05

Reiterated Buy on Strong Risk‑Reward Ahead of REMAIN‑1 Pivotal Data; $8 Price Target Unchanged

TIPRANKS
·
Apr 29

Fractyl Health announces annual shareholder meeting

Reuters
·
Apr 25

Fractyl Health Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
Apr 24

Health Rounds: Procedure to treat type 2 diabetes helps keep off weight after patients stop GLP-1 drugs

Reuters
·
Apr 24